Trio Of Wall Street Firms Up Array BioPharma Price Targets

By: via Benzinga
Array BioPharma Inc (NASDAQ: ARRY) lept higher Friday following an announcement that it acquired international rights to Encorafenib ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.